Validation of an HPLC-UV method for the determination of ceftriaxone sodium residues on stainless steel surface of pharmaceutical manufacturing equipments

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 2, 2011, Pages 247-252

  Akl, Magda A ^a   Ahmed, Mona A ^b   Ramadan, Ahmed ^a  

^a Mansoura University   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Ceftriaxone sodium; Cleaning validation; HPLC UV; Residues; Swab analysis

Indexed keywords

ACETONITRILE; CEFTRIAXONE; DRUG RESIDUE; STAINLESS STEEL; WATER;

ACCURACY; ARTICLE; BIOCHEMICAL EQUIPMENT; CLEANING; DRUG MANUFACTURE; DRUG STABILITY; EXTRACTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; SURFACE PROPERTY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INDUSTRY; EQUIPMENT AND SUPPLIES; LIMIT OF DETECTION; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 79952241989     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.020     Document Type: Article

References (23)

1. Guide to Inspections Validation of Cleaning Processes, U.S. Food and Drug Administration, (FDA), Office of Regulatory Affairs, Washington, DC, 1993, pp. 1-6, (accessed 20.04.2009). http://www.fda.gov//ora/inspect_ref/igs/valid.html.
2. Klinkenberg R., Streel B., Ceccato A. Development and validation of a liquid chromatographic method for the determination of the amlodipine residues on manufacturing equipment surfaces. J. Pharm. Biomed. Anal. 2003, 32:345-352.
3. Fazio T.T., Singh A.K., Kedor-Hackmann E.R.M., Santoro M.I.R.M. Quantitative determination and sampling of azathioprine residues for cleaning validation in production area. J. Pharm. Biomed. Anal. 2007, 43:1495-1498.
4. Mirza T., Lunn M.J., Keeley F.J., George R.C., Bodenmiller J.R. Cleaning level acceptance criteria and a high pressure liquid chromatography procedure for the assay of Meclizine Hydrochloride residue in swabs collected from pharmaceutical manufacturing equipment surfaces. J. Pharm. Biomed. Anal. 1999, 19:747-756.
5. The Merck Index 2001, 335. Merck & Co., Whitehouse Station, NJ. 13th ed. S. Budavari (Ed.).
6. Eric J.S., Agbaba D., Zivanov-Stakic D., Vladimirov S. HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. J. Pharm. Biomed. Anal. 1998, 18:893-898.
7. Marini D., Balestrieri F. Determination of ceftriaxone by HPLC. Farmaco 1986, 41:172-176.
8. Bowman D.B., Aravind M.K., Miceli J.N., Kauffman R.E. Reversed-phase high-performance liquid chromatographic method to determine ceftriaxone in biological fluids. J. Chromatogr. 1984, 309:209-213.
9. 2 bonded-phase column. J Chromatogr. 1983, 273:357-366.
10. Jungbluth G.L., Jusko W.J. Ion-paired reversed phase high-performance liquid chromatography assay for determination of ceftriaxone in human plasma and urine. J. Pharm. Sci. 1989, 78:968-970.
11. Joshi S. HPLC separation of antibiotics present in formulated and unformulated samples. J. Pharm. Biomed. Anal. 2002, 28:795-809.
12. Al-Rawithi S., Hussein R., Raines D.A., AlShowaier I., Kurdi W. A sensitive assay for the determination of cefazolin or ceftriaxone in plasma utilizing LC. J. Pharm. Biomed. Anal. 2000, 22:281-286.
13. Pajchel G., Owski K.P., Tyski S. CE versus LC for simultaneous determination of amoxicillin/cluvalanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections. J. Pharm. Biomed. Anal. 2002, 29:75-81.
14. Deyi Z., Yongjun M.A., Min Z., Li L.I., Hui C. Determination of ceftriaxone sodium in pharmaceutical formulations by flow injection analysis with acid potassium permanganate chemiluminiscence detection. Anal. Sci. 2006, 22:183-186.
15. Nozal M.J., Bernal J.L., Jimenez J.J., Martin M.T., Diez F.J. Development and validation of a liquid chromatographic method for determination of lacidipine residues on surfaces in the manufacture of pharmaceuticals. J. Chromatogr. A 2004, 1024:115-122.
16. Nozal M.J., Bernal J.L., Toribio L., Martin M.T., Diez F.J. Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals. J. Pharm. Biomed. Anal. 2002, 30:285-291.
17. Nozal M.J., Bernal J.L., Toribio L., Martin M.T., Diez F.J. Validation of a liquid chromatographic method for the determination of ranitidine hydrochloride residues on surfaces in the manufacture of pharmaceuticals. J. Chromatogr. A 2001, 919:87-93.
18. Lambropoulos J., Spanos G.A., Lazaridis N.V. Development and validation of an HPLC assay for fentanyl, alfentanil, and sufentanil in swab samples. J. Pharm. Biomed. Anal. 2000, 23:421-428.
19. Fakutsu N., Konse T., Kawasaki T., Saito K., Nakazawa H. Determination of cefmetazole residue at pharmaceutical manufacturing facilities by chemiluminescence flow injection analysis. J. Pharm. Biomed. Anal. 2006, 41:599-602.
20. Boca B., Apostolides Z., Pretorius E. A validated HPLC method for determining residues of a dual active ingredient anti-malarial drug on manufacturing equipment surfaces. J. Pharm. Biomed. Anal. 2005, 37:461-468.
21. United States Pharmacopoeia, 32nd ed., 2010.
22. ICH Harmonised Tripartite Guideline, Q2A, Text on Validation of Analytical Procedures, October 27, 1994.
23. ICH Harmonised Tripartite Guideline, Impurities in New Drug Products, 3B(R2), Current Step 4 version, 2 June 2006.